Aadi Bioscience, Inc. (AADI)

Aadi Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	35	50	313	505	46	25
Market Cap Growth	-67.52%	-84.17%	-37.97%	992.91%	82.44%	-63.32%
Enterprise Value	-52	-58	142	356	52	-13
PE Ratio	-	-0.75	-5.17	-4.56	-10.34	-1.09
PS Ratio	1.47	2.03	20.57	450.53	3.17	-
PB Ratio	0.39	0.47	1.98	3.70	-3.71	0.69
P/FCF Ratio	-0.94	-0.78	-6.25	-22.46	-3.64	-1.05
P/OCF Ratio	-0.99	-0.83	-6.31	-22.50	-3.64	-1.06
EV/Sales Ratio	-1.24	-2.38	9.34	318.04	3.56	-
EV/EBITDA Ratio	0.44	0.89	-2.38	-3.26	-20.91	0.56
EV/EBIT Ratio	0.43	0.89	-2.36	-3.26	-19.53	0.56
EV/FCF Ratio	0.48	0.91	-2.84	-15.85	-4.09	0.54
Debt / Equity Ratio	0.01	0.01	0.01	0.00	-0.82	0.00
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	-0.01	-4.13	-0.01
Debt / FCF Ratio	-0.02	-0.02	-0.03	-0.03	-0.81	-0.01
Quick Ratio	4.69	4.33	9.26	9.76	0.62	11.57
Current Ratio	5.16	4.72	9.56	9.90	0.62	11.87
Asset Turnover	0.18	0.16	0.09	0.01	0.39	0
Interest Coverage	-296.97	-283.70	-262.10	-164.55	-3.27	-
Return on Equity (ROE)	-61.80%	-52.50%	-43.20%	-122.50%	-16.20%	-53.30%
Return on Assets (ROA)	-51.50%	-44.30%	-37.30%	-109.30%	-11.90%	-49.00%
Return on Capital (ROIC)	-81.44%	-67.57%	-39.17%	-81.17%	117.14%	-66.60%
Earnings Yield	-196.03%	-132.75%	-19.33%	-21.95%	-9.67%	-91.95%
FCF Yield	-174.72%	-128.45%	-16.00%	-4.45%	-27.51%	-95.19%
Buyback Yield / Dilution	-0.44%	-19.58%	-152.27%	-250.99%	6.04%	-19.62%
Total Shareholder Return	-0.44%	-19.58%	-152.27%	-250.99%	6.04%	-19.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).